Table 2.
Overall (N = 6,751) | Fully Vaccinated (N = 1,779) | In Vaccination Window (N = 1,420) | Before Vaccination (N = 3,552) | p-Value | |
---|---|---|---|---|---|
Cardiovascular | |||||
Coronary artery disease* | 12.9% | 14.1% | 12.4% | 12.6% | 0.247 |
Congestive heart failure | 12.2% | 13.0% | 10.8% | 12.4% | 0.170 |
Conduction abnormalities | 12.7% | 13.8% | 12.9% | 12.1% | 0.201 |
Valvular heart disease | 3.9% | 4.6% | 3.5% | 3.80% | 0.52 |
Pericarditis | 0.52% | 0.62% | 0.42% | 0.51% | 0.738 |
Myocarditis | 0.04% | 0.11% | 0.00% | 0.03% | 0.256 |
Hypertension without complications | 42.6% | 44.5% | 42.5% | 41.8% | 0.168 |
Hypertension with complications | 12.9% | 13.4% | 11.8% | 13.1% | 0.320 |
Hypotension | 3.5% | 3.7% | 3.6% | 3.4% | 0.854 |
Peripheral vascular disease | 6.8% | 7.3% | 5.8% | 7.0% | 0.236 |
Hyperlipidemia | 27.1% | 29.5% | 27.7% | 25.7% | 0.012 |
Neurologic | |||||
Cerebrovascular event | 3.5% | 4.6% | 2.7% | 3.2% | 0.011 |
Neurological disorder | 13.3% | 13.1% | 11.8% | 13.9% | 0.121 |
Peripheral neuropathy | 8.2% | 8.4% | 7.7% | 8.4% | 0.752 |
Pulmonary | |||||
Pulmonary embolism | 0.8% | 0.7% | 0.7% | 0.8% | 0.826 |
Chronic lung disease | 21.7% | 22.5% | 21.2% | 21.5% | 0.620 |
Pulmonary hypertension | 2.7% | 2.9% | 2.3% | 2.8% | 0.555 |
Respiratory infection | 7.1% | 5.6% | 5.4% | 8.5% | <0.001 |
Gastrointestinal | |||||
Obesity | 9.2% | 8.3% | 9.7% | 9.4% | 0.294 |
Metabolic disorder | 4.8% | 4.7% | 4.7% | 4.9% | 0.943 |
Malnutrition | 2.5% | 2.6% | 2.1% | 2.6% | 0.547 |
Upper GI disorders | 10.8% | 10.5% | 10.7% | 11.0% | 0.839 |
Lower GI disorders | 0.8% | 1.0% | 0.5% | 0.9% | 0.284 |
Liver/gallbladder disease | 4.4% | 4.1% | 4.7% | 4.4% | 0.700 |
Pancreatic disease | 1.6% | 1.5% | 1.7% | 1.5% | 0.916 |
GI bleed | 2.1% | 1.7% | 1.9% | 2.3% | 0.383 |
Hematological | |||||
Anemia | 1.1% | 1.0% | 1.2% | 1.0% | 0.833 |
Coagulopathy | 2.8% | 3.0% | 2.5% | 2.8% | 0.618 |
White blood cell disorder | 5.8% | 6.0% | 4.9% | 6.0% | 0.317 |
Genitourinary | |||||
Renal disease | 19.1% | 20.0% | 17.7% | 19.1% | 0.267 |
Electrolyte abnormalities | 17.2% | 17.7% | 15.8% | 17.5% | 0.319 |
Urinary disorders | 5.7% | 5.9% | 5.0% | 5.9% | 0.409 |
Urologic disorders | 4.1% | 4.6% | 3.5% | 4.0% | 0.290 |
Gynecological disorders | 2.9% | 2.9% | 3.0% | 2.8% | 0.939 |
Pregnancy | 0.8% | 0.9% | 1.1% | 0.6% | 0.236 |
Other | |||||
Musculoskeletal disorders | 32.5% | 35.7% | 31.1% | 31.5% | 0.004 |
Diabetes | 24.9% | 26.1% | 22.9% | 25.1% | 0.101 |
Trauma | 15.5% | 14.7% | 15.6% | 15.9% | 0.533 |
Substance abuse | 12.0% | 10.6% | 10.4% | 13.4% | 0.001 |
Infection | 11.0% | 9.7% | 10.8% | 11.7% | 0.082 |
Psychiatric disorders | 10.0% | 9.6% | 8.5% | 10.9% | 0.028 |
Thyroid disease | 8.4% | 9.0% | 8.5% | 8.1% | 0.496 |
Malignancy | 6.6% | 6.6% | 7.5% | 6.3% | 0.257 |
Eyes, ears, nose and throat disorders | 6.5% | 7.1% | 5.7% | 6.5% | 0.290 |
Toxins | 5.4% | 6.0% | 7.2% | 4.3% | <0.001 |
Skin disorders | 4.5% | 4.7% | 4.6% | 4.3% | 0.715 |
Autoimmune disorders | 1.3% | 1.5% | 1.3% | 1.2% | 0.622 |
Allergic reaction | 1.4% | 1.3% | 2.7% | 0.9% | <0.001 |
Boldface type denotes statistical significance. GI = gastrointestinal; SD = standard deviation.
Includes acute coronary syndrome.